Interesting facts
Interesting Facts about 4-[2-(11,17-Dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethoxy]-4-oxo-butanoic acid
This compound is part of a fascinating category known for its complex structure and potential therapeutic applications. Below are some intriguing aspects that highlight its significance:
- Complex Structure: The intricate arrangement of its molecular framework suggests that it may exhibit unique reactivity and functionality. Specifically, the presence of multiple *hydroxyl* and *carbonyl* groups may contribute to its distinctive chemical behavior.
- Potential Biological Activity: Compounds similar to this one often engage in significant biological activities. Interestingly, some derivatives are studied for their role in *anti-inflammatory* and *antioxidant* mechanisms, which hold potential in pharmacological applications.
- Steroid-Like Character: Given its structural components, this compound may share characteristics with steroidal compounds. Steroids are known for their role in regulating biological processes, which raises questions about this compound's potential biological roles.
- Ethoxy and Butanoic Acid Moieties: The ethoxy group in the structure provides potential for modifications, enhancing its solubility and bioavailability. Additionally, the presence of the butanoic acid segment could endow it with energy-related properties.
- Synthetic Interest: Chemists are often intrigued by compounds with such elaborate structures as they can serve as important intermediates in the synthesis of more complex molecules. This makes them valuable in both industry and research scenarios.
As we delve deeper into understanding this compound, it serves as a reminder of the incredible complexity found in organic chemistry, showcasing not just the aesthetic charm of molecular design, but also the potential for discovery in the realms of medicine and beyond.
Synonyms
1231184-90-9
4-(2-{1,10-dihydroxy-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl}-2-oxoethoxy)-4-oxobutanoic acid
4-[(11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl)oxy]-4-oxobutanoic acid
CERAPP_12744
DTXSID20859234
BBL033641
STL372790
AKOS025247954
4-[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy]-4-oxobutanoic acid
VS-12196
DB-045769
EN300-295974
Solubility of 4-[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethoxy]-4-oxo-butanoic acid
The solubility of the compound with the formula C28H37FO7 can be considered within the context of its structural complexity and the presence of functional groups. Here are some key points to consider:
In summary, the solubility of 4-[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethoxy]-4-oxo-butanoic acid is complex and will depend heavily on the solvent environment and temperature conditions. Understanding its solubility behavior is crucial for applications in pharmaceuticals and related fields where the mobility of the compound is of significant interest.